Skip to main content

Table 1 Correlation of histology markers with survival

From: Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma

Treatment arm Parametric survival Weibull p
Necrosis HIF-1α perinecrotic area HIF-1α vital tumor P-PRAS40 P-RPS6 Iba1
Nimotuzumab 0.7360 0.3733 0.6135 0.2365 0.6078 0.5149
Control 0.1003 0.4436 0.7257 0.6929 0.2967 0.0275
  1. Univariate Weibull parametric survival analysis was performed for the listed parameters
Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us